Abstract:Selective Mcl-1 inhibitors may overcome the drug resistance caused by current anti-apoptotic Bcl-2 protein inhibitors in tumors with Mcl-1 overexpression. Based on previously discovered compounds with a 3-phenylthiophene-2-sulfonamide core moiety, in this work, we have obtained new compounds with improved binding affinity and/or selectivity under the guidance of structure-based design. The most potent compounds achieved sub-micromolar binding affinities to Mcl-1 (Ki ∼ 0.4 μM) and good cytotoxicity (IC50 < 10 μM) on several tumor cells. 15N-heteronuclear single-quantum coherence NMR spectra suggested that these compounds bound to the BH3-binding groove on Mcl-1. Several cellular assays revealed that FWJ-D4 as well as its precursor FWJ-D5 effectively induced caspase-dependent apoptosis, and their target engagement at Mcl-1 was confirmed by co-immunoprecipitation experiments. Treatment with FWJ-D5 at 50 mg/kg every 2 days on an RS4;11 xenograft mouse model for 22 days led to 75% reduction in tumor volume without body weight loss.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00690?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00690</a>.Information of the predicted hydration sites in the Mcl-1 binding pocket, flow cytometric analysis of three selected compounds, and HPLC traces for the reported compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00690/suppl_file/jm1c00690_si_001.pdf">PDF</a>)Molecular formula strings of all reported compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00690/suppl_file/jm1c00690_si_002.csv">CSV</a>)Structural files of the predicted binding modes of YCW-E10 and FWJ-D4 with Mcl-1 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00690/suppl_file/jm1c00690_si_003.zip">ZIP</a>)Statement on the ethnicity of all animal experiments performed in this work (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00690/suppl_file/jm1c00690_si_004.pdf">PDF</a>)This article has not yet been cited by other publications.

Marinopyrrole Derivatives With Sulfide Spacers As Selective Disruptors Of Mcl-1 Binding To Pro-Apoptotic Protein Bim

Cyclic marinopyrrole derivatives as disruptors of Mcl-1 and Bcl-x(L) binding to Bim.

Design, synthesis and evaluation of marinopyrrole derivatives as selective inhibitors of Mcl-1 binding to pro-apoptotic Bim and dual Mcl-1/Bcl-xL inhibitors.

Cyclic Marinopyrrole Derivatives as Disruptors of Mcl-1 and Bcl-xL Binding to Bim

Design, Synthesis, And Interaction Study Of Quinazoline-2(1h)-Thione Derivatives As Novel Potential Bcl-X(L) Inhibitors

Development of 3‐phenyl‐n‐(2‐(3‐phenylureido)ethyl)‐thiophene‐2‐sulfonamide Compounds As Inhibitors of Antiapoptotic Bcl‐2 Family Proteins

Pyoluteorin derivatives induce Mcl-1 degradation and apoptosis in hematological cancer cells

Structure-Based Optimization of 3-Phenyl-<i>N</i>-(2-(3-phenylureido)ethyl)thiophene-2-sulfonamide Derivatives as Selective Mcl-1 Inhibitors

Discovery of Marinopyrrole A (maritoclax) As a Selective Mcl-1 Antagonist That Overcomes ABT-737 Resistance by Binding to and Targeting Mcl-1 for Proteasomal Degradation*

Structure-Based Optimization of 3-Phenyl- N -(2-(3-phenylureido)ethyl)thiophene-2-sulfonamide Derivatives as Selective Mcl-1 Inhibitors

Structure-Based Design and Structure-Activity Relationship Analysis of Small Molecules Inhibiting Bcl-2 Family Members

Novel Mcl-1/Bcl-2 dual inhibitors created by the structure-based hybridization of drug-divided building blocks and a fragment deconstructed from a known two-face BH3 mimetic.

De novo design, synthesis and evaluation of benzylpiperazine derivatives as highly selective binders of Mcl-1.

Design, synthesis and preliminary biological studies of pyrrolidine derivatives as Mcl-1 inhibitors.

Discovery and development of thiazolidine-2,4-dione derivatives as Bcl-2/Mcl-1 dual inhibitors

Discovery of 3,5-Dimethyl-4-Sulfonyl-1 H -Pyrrole-Based Myeloid Cell Leukemia 1 Inhibitors with High Affinity, Selectivity, and Oral Bioavailability

Structure‐based Design, Synthesis, and Evaluation of Bcl‐2/Mcl‐1 Dual Inhibitors

A Novel BH3 Mimetic S1 Potently Induces Bax/Bak‐dependent Apoptosis by Targeting Both Bcl‐2 and Mcl‐1

Novel Bcl‐2 Inhibitors: Discovery and Mechanism Study of Small Organic Apoptosis‐Inducing Agents

A novel small molecule inhibitor targeted at Bcl-2

Design, Synthesis and Preliminary Bioactivity Studies of Indomethacin Derivatives As Bcl-2/Mcl-1 Dual Inhibitors